Trusted for over a decade, a US-based supplier with a robust catalog: peptides including GLPs, BPC-157, and TB-500, plus nootropics and other harder-to-find research compounds. Free US shipping on qualifying orders, worldwide delivery where eligible, and discounts when paying with crypto.
The uncensored home of r/PeptideSource
- The official website and online forum of the r/PeptideSource subreddit community.
- Our online forum allows more open discussion than what is allowed on Reddit.
- Check out our vetted suppliers below.
| Peak | RT (min) | Area % |
|---|---|---|
| 1 | 3.21 | 0.21 |
| 2 | 7.64 | 0.48 |
| 3 | 12.48 | 99.12 |
| 4 | 16.90 | 0.19 |
Vetted suppliers
Vendors trusted, vetted, and recommended by the Peptide Source community. Several of them participate actively on the forum.
US-based and in the research peptide business for over a decade, with peptides, research liquids, and capsules. Weekday orders placed before 1 PM Eastern ship the same day, and shipping is free over $99.
A US-based supplier geared toward bulk and lab-scale orders, with a wide peptide range from BPC-157 and TB-500 to IGF-1 LR3, CJC-1295, and ipamorelin. Same-day shipping on weekday orders before 1 PM Eastern and free shipping over $99. You’ll need an account to browse.
Why a forum outside Reddit?
r/PeptideSource is one of the first and largest peptide communities online, but Reddit’s rules limit what can be said there. The Peptide Source forum is run by the same community, without the same limits.
On r/PeptideSource
- General peptide discussion and questions
- Research news and published studies
- Community announcements
Also on the Peptide Source forum
- Vendors named and reviewed openly
- Pricing, sourcing, and shipping experiences
- Full third-party lab results, posted as they come in
- Group tests organized and funded by members
- Topics that would be removed on Reddit
Studies
All studies- The FDA’s 2026 peptide compounding changes, explained BPC-157, TB-500, and ten other peptides came off the FDA’s restricted list, and an advisory panel backed six for compounding. Here is what actually changed and what hasn’t.
- Retatrutide’s Phase 3 results: what four trials showed Lilly’s triple-agonist produced average weight loss approaching 30% in its pivotal trials. A look at the numbers, the side effects, and the timeline to approval.
- GHK-Cu: what 50 years of copper peptide research supports Strong evidence for skin and wound repair, intriguing gene-expression data, and very little on injection. Where the research on GHK-Cu actually stands.
- Welcome to the new Peptide Source The site has been rebuilt from scratch around what matters most here: the forum, the community’s recommended vendors, and a proper home for articles.
- How semaglutide lowers body weight: inside a 2020 rodent study Weight loss came from eating less, not burning more, and the drug reached appetite centers without crossing the blood-brain barrier.
- Selank and diazepam under chronic stress: a 2017 rat study Combining Selank with diazepam reduced anxiety-like behavior more than diazepam alone in chronically stressed rats. What that suggests, and why it calls for caution.